Clinical trial Recruiting at 1 site Interventional Ages 25 to 65

Multidisciplinary non-drug program to improve quality of life after solid organ transplant

Official title: Integrated Multidisciplinary Non-Pharmacological Treatment for Improving Health-Related Quality of Life in Solid Organ Transplant Recipients: A Randomized Single-Center Pilot Study

Run by The Mediterranean Institute for Transplantation and Advanced Specialized Therapies · NCT07870811 · Data updated 2026-11-12

A multidisciplinary, non-drug program using acupuncture, remote physical rehab, and brain-health activities is being tested to see if it can improve quality of life for adults at least one year after heart, kidney, liver, or lung transplant.

Quick facts

Study typeInterventional
Ages25 Years to 65 Years
SexAll
Enrollment140 (estimated)
SponsorThe Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Academic / other
Locations1 site (Palermo, Palermo)
StatusRecruiting
StartedApril 27, 2026
Main results expectedOctober 21, 2026
Study endsOctober 21, 2027
Registry record updatedNovember 5, 2026
Trial IDNCT07870811 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 25–65 who had a liver, kidney, heart, or lung transplant at least 1 year ago and who meet specific QoL criteria.

Probably not a fit

Patients with significant cognitive impairment, active graft rejection, or contraindications to exercise may not benefit or participate.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center study tests a non-pharmacological approach for solid organ transplant recipients. The program combines acupuncture, telerehabilitation-based physical therapy, and psychological/brain-health support to see if health-related quality of life and well-being can be improved. Eligibility includes adults 25–65 who are at least one year post-transplant with certain quality-of-life indicators and no contraindications to exercise. The trial will provide preliminary estimates of impact and assess feasibility of implementing this approach in clinical practice.

Why it matters

Potential benefit: If successful, participants may experience improved quality of life and well-being after transplantation.

How similar studies have gone: Previous research in non-pharmacological support for transplant recipients suggests potential QoL benefits but this specific multidisciplinary combination is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 25 years and ≤ 65 years;
* Solid organ transplantation (liver, kidney, heart, or lung) performed at least 1 year prior to enrollment, with good graft functional recovery according to organ-specific criteria;
* Ability to understand and independently complete questionnaires;
* Ability to provide written informed consent;
* Absence of clinical contraindications to therapeutic exercise;
* Adequate cognitive status;
* SF-36 score \< 50 or Distress Thermometer (DT) score ≥ 4 and Pittsburgh Sleep Quality Index (PSQI) score ≥ 5.

Exclusion Criteria:

* Diagnosis of severe cognitive impairment, acute psychiatric illness, or significant hearing or visual disability;
* Severe ongoing complications or comorbidities that would prevent participation in the physiotherapy program;
* Unstable immunosuppressive therapy and/or evidence of ongoing graft rejection;
* Diagnosis of active malignancy;
* Pregnancy.

Where it's running

  • IRCCS ISMETT - Istituto Mediterraneo per i Trapianti e le Terapie ad Alta Specializzazione
    Palermo, Palermo, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.